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Background: Adherence to antiretroviral therapy (ART) is beneficial in reducing the risk of emergence of HIV
resistant strains. Adherence to ART among Persons Living with HIV/AIDS (PLWHA) is influenced by several factors
related to the patient, the medication, and health facilities. In Togo, previous studies on adherence to ART have
reported good adherence to ART during the first year of follow-up. However these may hide many disparities dues
to cultural specificities which may differ across geographic areas of the country. We sought to determine the level
of adherence to ART and document the associated factors among PLWHA at the regional hospital of Sokodé, Togo.
Methods: This was an analytical cross-sectional study conducted from May to July 2013 at the regional hospital of
Sokodé among 291 PLWHA who had been on ART for at least three months before the study.
Results: A total of 291 PLWHA on ART were enrolled in the study. The mean age (±SD) was 37.3 ± 9.3 years and
the sex ratio (Male/Female) was 0.4. Among them, 195 (67.0%) were living with their partners and 210 (72.2%) had
formal education. Two-thirds (194/291; 66.7%) of the PLWHA interviewed lived in urban areas. The global adherence
to ART was 78.4%; the factors associated with ART adherence were: level of education (aOR = 3.54; p = 0.027), alcohol
consumption (aOR = 0.43; p = 0.033), ART perception (aOR = 2.90; p = 0.026) and HIV status disclosure to sexual partner
(aOR = 7.19; p≤ 0.001).
Conclusion: Although the level of adherence to ART in this study was higher than those reported in some studies in
Sub-Saharan Africa, it remains sub-optimal and needs improvement. This may therefore hinder the implementation of
efficient interventions related to access to ART services.
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The number of people living with HIV and AIDS
(PLWHA) was estimated at 23.5 million in Sub-Saharan
Africa, where 1.2 million of deaths related to AIDS had
been recorded in 2012 [1]. The “3 by 5” and “Treatment
2015” an initiative launched jointly by WHO and
UNAIDS in 2003 and 2011 respectively have created a
truly dynamic environment in HIV care for PLWHA in
developing countries. Access to antiretroviral treatment* Correspondence: mlandoh@yahoo.fr
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unless otherwise stated.(ART) has considerably expanded since then, to reaching
9.7 million persons in resource-limited countries in late
2012 [2]. This has led to the reduction of not only the
number of new HIV infections, but also in AIDS mortality
and -its related co-morbidities. The introduction of ART
in the treatment of PLWHA has dramatically changed
the course of HIV/AIDS epidemic, making AIDS a
chronic disease. Thus, new issues related to the chron-
icity of the disease have appeared, including the adher-
ence to ART [3].
Indeed, adherence to ART is essential for long-term
therapeutic success and is therefore a major concern to
ART programs. Studies have shown that good adherenceis is an Open Access article distributed under the terms of the Creative
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in reducing the risk of emergence of HIV resistance strains,
but also in improving the health status of the PLWHA
[4,5]. To date, research on ART adherence includes meth-
odologically rigorous investigations; however the measure-
ment of adherence to ART raises many questions because
there is no standardized measurement tool which may be
appropriate in all cases. In low-income countries, several
studies have been conducted among PLWHA on ART
in order to measure their adherence to ART [4-14]. The
methods used were either subjective methods such as self-
reporting questionnaires [7,8], or objective methods such as
counting the remaining tablets, or often the combination of
these two methods [6]. Adherence to ART in these studies
was estimated at 55.4% in Congo [6] and 93% in Senegal
[9]. It is also well documented that adherence to ART
among PLWHA is influenced by several factors related to
the patient, the medication, the psychosocial environment
and the medical care facilities [15,16].
In Togo, programs against HIV/AIDS introduced ART
in the late 90s, and the number of PLWHA on ART
increased from 6,721 in 2006 to 30,334 in 2012, with an
increase of ART coverage from 20% in 2006 to 49.3% in
2012 [17]. Previous nationwide studies on adherence to
ART in Togo had reported rates of adherence during the
first year of follow-up, estimated at 89.6% [18], in 2009
and 78% in 2011 [17]. However these rates hide many
geographical disparities dues to cultural specificities which
may differ across geopolitical zones of the country. The
assessment of the adherence to ART could be an oppor-
tunity to identify potential obstacles to taking medication
in order to prevent treatment failure and the development
of drug resistance among PLWHA. In addition, published
studies about factors that influence adherence to ART in
Togo are limited. We sought to determine the level of
adherence to ART and to document the factors associated
with ART adherence among PLWHA at the regional
hospital of Sokodé in Togo.
Methods
Study design
This was a cross-sectional study conducted at regional hos-
pital of Sodoké over a period of three months from May to
July 2013 among PLWHA on ART for at least three months.
Setting
The regional hospital of Sokodé is a health reference
center of the central region which is one of the six
health regions of Togo. The regional hospital of Sokodé
is located about 350 km from the capital Lomé. It serves
four health districts with a total population of 654,074
inhabitants in 2013 [19]. Around 45% of the 1,869
PLWHA registered in the central region are followed
up in this hospital [17].Study population and sampling (Figure 1)
This study targeted PLWHA who were under ART and
followed up in the regional hospital of Sokodé.
Of the 843 PLWHA who were followed in the regional
hospital of Sokode, 798 were at least 15 years old [17].
We used a purposive and comprehensive sampling to
include PLWHA aged 15 years or older, who were taking
ART for at least three months and were followed up in
the regional hospital of Sokodé [20]. All patients attend-
ing the HIV care clinic for follow up during the study
period and who met the inclusion criteria were invited
to participate in the study.
HIV positive pregnant women were not included in
the survey because of the difference of ART regimen for
this target group.
Data collection
Data were collected through a questionnaire-assisted
interview in French or in the local language, conducted
by the clinic officers to ensure good understanding of
the questions.
The questionnaire included socio-demographic infor-
mation, clinical features, information on the adherence to
ART and information on HIV/AIDS knowledge. Data on
HIV status disclosure to the sexual partner and sexual be-
havior aspects were collected only among sexually active
PLWHA. Sexual activity was defined as reporting at least
one sexual partner during the previous 3 months [20].
To quantify the level of adherence in our study, three
measurements tools were used, including: i) self-reportingof
missed doses: During interview of the patient for a possible
missed medication during the last four days; the patient
was considered adherent if he had not missed to take any
medication during the previous four days. ii) Counting
the remaining tablets: The caregiver records the num-
ber of tablets or capsules remaining and evaluates ad-
herence by considering a missed tablet or capsule as a
tablet or capsule absorbed. In Togo, PLWHA on ART
are requested to renew their treatment every month
during the follow up appointment at the HIV care
clinics at least three days before the end of their previ-
ous prescription. Patients with a percentage of intake
tablets or capsules equal to or greater than 95% were
considered adherent. iii) the rate of prescriptions renewed,
here expressed as the number of appointments honored
during the three months preceding the survey. Patients
who did not fail any appointment were classified as
adherent.
The global index of adherence was obtained by sum-
ming the results of the different measurement of adher-
ence methods used in the study (a coefficient assigned to
each item with 0 for non adherence and 1 for adherence).
Thus the global index of adherence was used to classify
PLWHA in two categories according to the level of
Figure 1 Flow chart of study sampling of PLWHA on ART in Sokodé, Togo.
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good adherence (index from 2 to 3).
Data analysis
Data entry was performed using EpiData software version
3.1 and analyzed in SPSS Inc version 17.0 (SPSS Inc,
Chicago, IL, USA).
For continuous variables, mean, median and standard
deviation were calculated while for categorical variables
we calculated proportions. Our primary outcome of
interest was people living with HIV who were adherent
to ART compared to PLWHA who were non-adherent.
Pearson chi-square test or Fisher′s exact test were used
when appropriate in bivariate analysis.
Multivariate backwards stepwise logistic regression
analysis was performed to identify independent risk fac-
tors for the primary of being adherent or non-adherent
to ART. All variables significant during bivariate analysis
at a p-value less than 0.05 were introduced in a logistic
regression model to appreciate the adjusted effect and
derive the adjusted odds ratio (aOR) of each on the pri-
mary outcome, "global adherence to ART" expressed as
a dichotomous variable. A 95% level of confidence was
applied throughout.Ethical issues
This study was approved by the National AIDS and STI
Program of Togo (Ref N° 098/2013/MS/DSSP/PNLS-IST).
We obtained consent from patients that participated in
the study. For each person interviewed, the objectives,
benefits to participate in the survey and progress of the
investigation were clearly stated as well as their right
to interrupt the interview without justification. An in-
formed consent form was signed after the verbal explan-
ation was made by the investigating officer in the
language understood by the participant. The survey was
anonymous and confidential. The respondents’ names
were not recorded to ensure their confidentiality; these
were replaced by numbers.
Results
Characteristics of the study population
Of the 458 PLWHA on ART who were seen in the hos-
pital, 317 consented to participate in the study. Of these,
291 PLWHA completed the interview including 201
(69.1%) women. The mean age of the participants was
37.3 ± 9.3 years (range: 18–68 years). Among the 291
PLWHA, 195 (67.0%) were living with their partners
and 210 (72.2%) had at least primary level of education.
Yaya et al. BMC Public Health 2014, 14:1308 Page 4 of 10
http://www.biomedcentral.com/1471-2458/14/1308Two-thirds (194/291; 66.7%) of the PLWHA interviewed
lived in urban areas.
On clinical and therapeutic level, 106 (36.4%) of the
PLWHA were at WHO clinical stage III and IV at the
time of the survey. The median duration of ART among
PLWHA was 35 months. At the last check-up prior to the
survey, the average of CD4 count was 381 ± 209cells/mm3
(range 9 to 1080 cells/mm3). Most PLWHA were on first-
line treatment (274/291; 94.2%) while 83.5% (243/291)
were on Zidovudine/Lamivudine/Nevirapine therapeutic
combination. At the time of the survey, 217 (74.6%) of the
PLWHA interviewed were sexually active since initiating
ART and of these, 60.9% (131/217) had disclosed their HIV
status to their sexual partner. In addition, 130 PLWHA
(60.5%) knew their sexual partner’s HIV status (Table 1).
ART adherence
Out of the 291 PLWHA who responded to the question-
naire, 212 (72.9%) had not skipped any tablet within four
days prior to the survey. Through this tool of measure, the
proportion of adherent was significantly higher among men
(81.1%; p <0.05); PLWHA in rural areas (81.4%; p < 0.05)
and among patients who had secondary education (85.7%;
p < 0.001). Adherence to ART was also significantly as-
sociated with alcohol consumption (p < 0.001), CD4 count
(p < 0.05), ART perception (p < 0.001), HIV-status disclos-
ure to sexual partner (p < 0.001) and knowledge of the
HIV sero-status of the sexual partner (p < 0.001) (Table 1).
Most of patients 250 (85.9%) had complied with the
appointment renewal of ART prescriptions. The propor-
tion of PLWHA who had respected appointments for
ART renewal decreased with the duration of being under
ART (p < 0.05). But this proportion was high among
patients who had secondary education (91.7%; p < 0.05),
among those who did not consume alcohol (88.3%;
p < 0.05) and among patients who had a good percep-
tion of ART (88.8%; p < 0.001). In addition, the number
of CD4 (p < 0.05), HIV-status disclosure to sexual partner
(p < 0.001), knowledge of the HIV sero-status of the sexual
partner (p < 0.001) were also associated with the adher-
ence to ART according to this method (Table 1).
On counting the remaining tablets, 218 PLWHA
(74.9%) had taken 95% or more of their ART. According
to this tool, adherence to ART increased significantly
with the age of the PLWHA (p < 0.05). This proportion
was high among patients who had high school educa-
tion (90.5%; p < 0.001), and among patients who had a
good perception of ART (78.7%; p < 0.001). With this
tool, the adherence was also significantly associated
with HIV-status disclosure to sexual partner (p < 0.001),
knowledge of the HIV sero-status of the sexual partner
(p < 0.001) (Table 1).
Among the PLWHA of regional hospital of Sokodé,
the global adherence to ART was calculated to be 78.4%(228/291). In bivariate analysis, the global adherence to
ART was statistically associated with the level of educa-
tion (p = 0.008), alcohol consumption (p ≤ 0.001), ART
perception (p ≤ 0.001), knowledge of HIV status of the
sexual partner (p ≤ 0.001), HIV status disclosure to the
sexual partner (p ≤ 0.001) and CD4 count at last check-
up (p = 0.022) (Table 1).
In multivariate analysis, four factors remained signifi-
cantly associated with good global adherence to ART:
PLWHA with a secondary education were about four
times more likely to have a good adherence to ART
(p = 0.022). Also, those who consumed alcohol daily were
significantly less likely to be adherent to ART (p = 0.041).
Patients who had a good perception of ART were almost
three times more likely to have good adherence to ART
compared to those who had poor perception (p = 0.026).
Finally, PLWHA who disclosed their HIV status to their
sexual partners (p = 0.000) were seven times more likely to
have good adherence to ART (Table 2). The knowledge of
HIV status of the sexual partner and the CD4’s count at
last check-up which were significant in bivariate analysis
were not significant in multivariate analysis.
Discussion
This study noted that four factors were associated with
the global adherence to ART among PLWHA on ART
attending the regional hospital of Sokodé. These were:
level of education, alcohol consumption, ART perception
and HIV status disclosure to sexual partner.
In fact we used three different tools in order to assess
the global adherence among the HIV-patient included in
the study. Firstly with the self-reporting tool, 72.9% of
the patients had a good adherence. Lower adherence
rate with this tool had been reported, 62.8% [4] in a
study conducted in Nigeria. The self-reporting method
is the most common tool used to access the adherence to
ART among HIV-patients [6-14]. Even if it is a subjective
tool to measure adherence to ART, we had used it in a
short period to minimize a recall bias which could occur.
With the second methods using pills count’s tool, 74.9%
PLWHA had good adherence to ART. Finally the number
of appointments honored during the three months pre-
ceding the survey showed that 85.9% of the PLWHA
were adherent. If this tool seems to have overestimated
the adherence to ART in our study, it remains a reliable
and reproducible method. Overall, the only advantage of
using these methods is that they are at low cost and easy
to implement [21]. The combination of these methods
provides more consistent and reliable results [14].
In our study, 78.4% of the PLWHA on ART globally
adhered to this treatment according to the three methods.
This adherence rate is sub-optimal (defined as less
than 95%), but it is higher than that reported by
Potchoo et al. (62.6%) in Lomé and Sokodé [22]. Many
Table 1 Descriptive data of PLWHA on ART at the regional hospital of Sokodé, Togo
Patients characteristics N (%) Measurement of adherence Global adherencen
(%)
p-value
Self-report Appointment pills count
n (%) n (%) n (%)
Sex * ° ° 0.283
Male 90 (30.9) 73 (81.1) 78 (86.7) 74 (82.2) 74 (82.2)
Female 201 (69.1) 139 (69.2) 172 (85.6) 144 (71.6) 154 (76.6)
Age ° ° * 0.168
Less than 25 years 26 (8.9) 21 (80.8) 25 (96.2) 17 (65.4] 21 (80.8)
25-35 years 109 (37.5) 74 (67.9) 91 (83.5) 75 (68.8) 79 (72.5)
More than 35 years 156 (53.6) 117 (75.0) 134 (85.9) 126 (80.8) 128 (82.1)
Marital status ° ° ° 0.330
Single/widower/divorced 96 (33.0) 64 (66.7) 84 (87.5) 68 (70.8) 72 (75.0)
Married/in couple 195 (67.0) 148 (75.9) 166 (85.1) 150 (76.9) 156 (80.0)
Education level ** * ** 0.008
Non schooled 81 (27.8) 61 (75.3) 73 (90.1) 59 (72.8) 67 (82.7)
Primary school 105 (36.1) 62 (59.0) 83 (79.0) 69 (65.7) 71 (67.6)
Secondary school 84 (28.9) 72 (85.7) 77 (91.7) 71 (84.5) 73 (86.9)
High levelschool 21 (7.2) 17 (81.0) 17 (81.0) 19 (90.5) 17 (81.0)
Religion 0.287
None or traditional 15 (5.2) 11 (73.3) 13 (86.7) 11 (73.3) 11 (73.3)
Islam 149 (51.2) 103 (69.1) 126 (84.6) 108 (72.5) 112 (75.2)
Christian 127 (43.6) 98 (77.2) 111 (87.4) 99 (78.0) 105 (82.7)
Place of residence * ° ° 0.131
Urban 194 (66.7) 133 (68.6) 165 (85.1) 145 (74.7) 147 (75.8)
Rural 97 (33.3) 79 (81.4) 85 (87.6) 17 (75.3) 81 (83.5)
Alcohol consumption ** * ° ≤0.001
No 223 (76.6) 173 (77.6) 197 (88.3) 173 (77.6) 187 (83.9)
Yes 68 (23.4) 39 (57.4) 53 (77.9) 45 (66.2) 41 (60.3)
Clinical WHO stage ° ° ° 0.242
Stage I 53 (18.2) 39 (73.6) 45 (84.5) 39 (73.6) 41 (77.4)
Stage II 132 (45.4) 95 (72.0) 113 (85.6) 101 (76.5) 109 (82.6)



















Table 1 Descriptive data of PLWHA on ART at the regional hospital of Sokodé, Togo (Continued)
Duration of ART therapy ° * ° 0.379
Less than one year 33 (11.3) 28 (84.8) 32 (97.0) 26 (78.8) 28 (84.8)
1 to3 years 126 (43.3) 94 (74.6) 113 (89.7) 95 (75.4) 101 (80.2)
More than 3years 132 (45.4) 90 (68.2) 105 (79.5) 97 (73.5) 99 (75.0)
CD4’s count (last check-up) * * ° 0.022
CD4 ≤ 350 116 (39.9) 76 (65.5) 93 (80.2) 83 (71.6) 83 (71.6)
CD4 > 350 175 (60.1) 136 (77.7) 157 (89.7) 135 (77.1) 145 (82.9)
Therapeutic’s line ° ° ° 0.574
1st line 274 (94.2) 200 (73.0) 236 (86.1) 204 (74.5) 216 (78.8)
2nd line 12 (4.1) 9 (75.0) 11 (91.7) 9 (75.0) 9 (75.0)
3rd line 5 (1.7) 3 (60.0) 3 (60.0) 5 (100.0) 3 (60.0)
Type of ART prescribed ° ° ° 0.310
Triomune 3 (1.0) 3 (100.0) 3 (100.0) 3 (100.0) 3 (100.0)
Duovir/EFV 36 (12.4) 22 (61.1) 31 (86.1) 25 (69.4) 27 (75.0)
Duovir/NVP 243 (83.5) 181 (74.5) 210 (86.4) 182 (74.9) 192 (79.0)
TNF/3TC/Aluvia 7 (2.4) 4 (57.1) 4 (57.1) 6 (85.7) 4 (57.1)
ABC/DDI/Aluvia 2 (0.7) 2 (100.0) 2 (100.0) 2 (100.0) 2 (100.0)
Reported side effects ° ° ° 0.988
No 240 (82.5) 175 (72.9) 210 (87.5) 178 (74.2) 188 (78.3)
Yes 51 (17.5) 37 (72.5) 40 (78.4) 40 (78.4) 40 (78.4)
ART perception by patient ** ** ** ≤0.001
Low 33 (11.3) 15 (45.5) 21 (63.6) 15 (45.5) 15 (45.5)
Good 258 (88.7) 197 (76.4) 229 (88.8) 203 (78.7) 213 (82.6)
HIV-status disclosure to sexual partner ** ** ** ≤0.001
No 84 (39.1) 39 (46.4) 62 (73.8) 48 (57.1) 46 (54.8)
Yes 131 (60.9) 106 (80.9) 119 (90.8) 109 (83.2) 113 (86.3)
Knowledge of the HIV sero-status
of the sexual partner
** * ** ≤0.001
No 85 (39.5) 43 (50.6) 65 (76.5) 49 (57.6) 51 (60.0)
Yes 130 (60.5) 102 (78.5) 116 (89.2) 108 (83.1) 108 (83.1)





















Table 1 Descriptive data of PLWHA on ART at the regional hospital of Sokodé, Togo (Continued)
Appointment’s adherence to ART
No 41 (14.1)
Yes 250 (85.9)
Pills count’s adherence to ART
No 73 (25.1)
Yes 218 (74.9)
Global adherence to ART
No 63 (21.6)
Yes 228 (78.4)



















Table 2 Predictor factors of adherence of PLWHA to ART
at the regional hospital of Sokodé, Togo
Patients characteristics aOR 95% for a OR p-value
Education level
Non schooled Ref
Primary school 0.77 [0.31 ; 1.92] 0.573
Secondary school 3.54 [1.16 ; 10.81] 0.027
High levelschool 1.16 [0.28 ; 4.84] 0.837
Alcohol consumption
No Ref
Yes 0.43 [0.20 ; 0.93] 0.033
ART perception
Low Ref
Good 2.90 [1.14 ; 7.35] 0.026
Knowledge of the HIV sero-status
of the sexual partner
No Ref
Yes 0.48 [0.17 ; 1.50] 0.209
HIV-status disclosure
No Ref
Yes 7.19 [2.38 ; 21.68] ≤0.001
CD4’s count (last check-up)
CD4≤ 350 Ref
CD4 > 350 1.87 [0.90 ; 3.88] 0.092
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level of adherence to ART of 95% in order to prevent de-
velopment of drug resistance and disease progression
[8,23]. In fact, an adherence to ART rate of 95% or greater
is essential to obtain a decrease of the viral load and mor-
bidity related to HIV infection. We found that 21.6% of
the patients were non-adherent to ART. This suggests all
the difficulties encountered by health personnel in health
facilities to retain PLWHA on ART to achieve good adher-
ence to treatment.
This finding is consistent with that found in a meta-
analysis which reported that 77% of patients in Africa
achieved adequate adherence. It is also similar to the
ART adherence rate reported in India (74%) [13], in
southern Ethiopia (74.4%) [24], but lower than ART
adherence rate reported in studies conducted in Kenya
(82%) [12], in Nepal (85.5%) [25] in West Africa (91.8%)
[26] and in Senegal (93.0%) [9]. However, this disparity
of adherence rates across studies may depend on the
context and the methods of measuring adherence which
may vary from a study to another.
Our study shows that PLWHA who attended at least
secondary level of school were almost 3.6 more likely to
adhere to ART. Indeed, formal education obviously plays
a major role in understanding and communicating in-
formation related to health care. Educated people mayshow better adherence to ART due to their ability to
follow the instructions related to the treatment given by
the health providers. Other studies [4,25] supported that
ART adherence rate was higher among HIV-infected
patients who had a high level of formal education. Our
finding was also consistent with that reported by
Kalichman et al. [27] in United States of America, who
had earlier identified low educational status as a major
factor of non-adherence to ART. Lower education was
found to have associations with barriers to receiving
HIV related health care, including ART. But this result
is not consistent with those reported by some other
studies in developing countries [15,28] which found that
the majority of patients who had low adherence to ART
were literate. In these studies, authors argued that situ-
ation may be due to the fact that these categories of
PLWHA had busy occupations that hindered taking
antiretroviral drugs.
Secondly, the consumption of alcohol was a poor predi-
cator of ART adherence. Alcohol consumption negatively
affects HIV-infected patients by reducing their adherence
to ART about 40% to 50% [29]. In fact alcohol intake
increases forgetfulness by patients of the times and in-
structions of ART medication. This finding is well docu-
mented in prior studies [14,25,28,30]. In a meta-analysis
of alcohol consumption among PLWHA [28], adher-
ence to ART was found low among individuals who
usually drank alcohol. Jaquet et al. [26] also reported
that alcohol consumption and hazardous drinking were
significantly associated with non-adherence to ART
among HIV-infected patients in West Africa. In a study
conducted in Botswana [31], about 40% of the partici-
pants reported that they had missed a dose of ART due
to alcohol consumption. The implication of this finding
is mainly to implement a strategic intervention toward
HIV-infected patients who have an alcohol use back-
ground in order to provide them appropriate health care,
psychological support and improve ART outcomes.
In our study, PLWHA who had good perception of
ART, were almost three times more likely to adhere to
ART. The level of belief in the benefits and effectiveness
of ART could also promote adherence as documented
by several studies [24,32,33]. This was particularly found
in patients who have experienced serious events related
to HIV infection and whose state of health has been im-
proved after ART initiation. In a cross-sectional mixed-
methods study carried out in Nepal, Wasti et al. [25]
found that negative perceptions could act as barriers to
adherence to ART. Our finding underscores the rele-
vance of health education during the patients’ visits
which could help them to overcome negative experi-
ences of the side effects of ART.
Finally, those who disclosed their HIV sero-status to
the sexual partner were nearly seven times more likely
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sero-status disclosure is a known predictor of increased
adherence to ART [4,10,11,25,30,34]. In fact, HIV dis-
closure could be the first stage of creating a supportive
relationship with the sexual partner and with the family,
and that would facilitate the acceptance and the con-
tinuation of ART. Literature suggests that HIV disclosure
facilitates ART adherence [11,34]. In a study conducted in
Ibadan, Nigeria, Olowookere et al. [10] reported that,
compared to the HIV positive patients who disclosed their
HIV status, those who were unwilling to disclose their
HIV status were more likely to be non-adherent to ART.
In a meta-analysis of adherence to ART in Sub-Saharan
Africa and North America, Mills et al. [30] found that
PLWHA who did not disclose their HIV status were more
likely to report frequent ART interruptions and fear to be
discriminated or stigmatized. Health care providers and
the policy makers need to convince HIV-infected patients
who are still reluctant to disclose their HIV status to do
so. These interventions should include social institutions
like nongovernmental organizations, HIV-infected persons
associations and confessional institutions which play an
important role in facilitating treatment, and promoting
adherence to ART.Limitations of study
The findings of this study should be interpreted in view of
some limitations. This study was conducted among
PLWHA followed up only at the regional hospital of CHR
Sodoké. Therefore, the sample may not be representative
of the whole country. Due to the cross-sectional study
design of this study, the variation of adherence of the
participants to ART which can occur over the time was
not assessed.Conclusion
The level of adherence to ART was sub-optimal at the
regional hospital of Sokodé. The level of education, alco-
hol consumption, ART perception, and HIV sero-status
disclosure to the sexual partner were the main factors
associated with the adherence to ART. Policy-makers,
NGOs and health care providers should give priority to
relevant interventions that focus on regular follow-up,
education of the PLWHA, the negative consequences of
alcohol consumption on ART adherence, and provide a
supportive environment that encourages HIV-infected
patients to disclose their HIV sero-status in confidence.
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